Spots Global Cancer Trial Database for Combination Treatment for Advanced Liver Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Combination Treatment for Advanced Liver Cancer
Official Title: Transarterial Chemoembolisation (TACE) Combined With Endovascular Implantation of Bare Stent and Iodine-125 Seed Strand for the Treatment of Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis Versus TACE Alone
Study ID: NCT02149771
Study Description
Brief Summary: The purpose of this study is to determine whether TACE combined endovascular stent implantation confers a survival benefit over TACE alone.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Contact Details
Name: Zhinping Yan, MD
Affiliation: Department of Interventional Radiology, Zhongshan Hospital, Fudan University
Role: PRINCIPAL_INVESTIGATOR
Name: Jianjun Luo, MD
Affiliation: Department of Interventional Radiology, Zhongshan Hospital, Fudan University
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
